Read More Analyst Ratings News Price Target Oppenheimer Maintains Outperform on ServiceNow, Raises Price Target to $775 By Benzinga Newsdesk Today, 7:18 AM Oppenheimer analyst Ray McDonough maintains ServiceNow (NYSE:NOW) with a Outperform and raises the price target from $700 to $775. NOW
Read More FDA News FDA Publishes Briefing Documents On Ardelyx Inc’s Kidney Disease Treatment By Bill Haddad Today, 7:18 AM -Reuters ARDX
Read More General News Politics White House’s National Security Advisor Jake Sullivan Says We Are Aware Of Reports Putin May Be Preparing To Enact Mobilization Measures By Benzinga Newsdesk Today, 7:18 AM - Reuters RSX
Read More Analyst Ratings News Price Target Barclays Maintains Underweight on Continental Resources, Raises Price Target to $67 By Benzinga Newsdesk Today, 7:18 AM Barclays analyst Jeanine Wai maintains Continental Resources (NYSE:CLR) with a Underweight and raises the price target from $64 to $67. CLR